174 related articles for article (PubMed ID: 31173928)
1. MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology.
Mittempergher L; Delahaye LJMJ; Witteveen AT; Spangler JB; Hassenmahomed F; Mee S; Mahmoudi S; Chen J; Bao S; Snel MHJ; Leidelmeijer S; Besseling N; Bergstrom Lucas A; Pabón-Peña C; Linn SC; Dreezen C; Wehkamp D; Chan BY; Bernards R; van 't Veer LJ; Glas AM
J Mol Diagn; 2019 Sep; 21(5):808-823. PubMed ID: 31173928
[TBL] [Abstract][Full Text] [Related]
2. Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells.
Cheng YH; Chen YC; Lin E; Brien R; Jung S; Chen YT; Lee W; Hao Z; Sahoo S; Min Kang H; Cong J; Burness M; Nagrath S; S Wicha M; Yoon E
Nat Commun; 2019 May; 10(1):2163. PubMed ID: 31092822
[TBL] [Abstract][Full Text] [Related]
3. Molecular Testing in Breast Cancer: Current Status and Future Directions.
Sun L; Wu A; Bean GR; Hagemann IS; Lin CY
J Mol Diagn; 2021 Nov; 23(11):1422-1432. PubMed ID: 34454106
[TBL] [Abstract][Full Text] [Related]
4. Using microarray-based subtyping methods for breast cancer in the era of high-throughput RNA sequencing.
Pedersen CB; Nielsen FC; Rossing M; Olsen LR
Mol Oncol; 2018 Dec; 12(12):2136-2146. PubMed ID: 30289602
[TBL] [Abstract][Full Text] [Related]
5. A Joint Bayesian Model for Integrating Microarray and RNA Sequencing Transcriptomic Data.
Ma T; Liang F; Oesterreich S; Tseng GC
J Comput Biol; 2017 Jul; 24(7):647-662. PubMed ID: 28541721
[TBL] [Abstract][Full Text] [Related]
6. RNA Analysis as a Tool to Determine Clinically Relevant Gene Fusions and Splice Variants.
Teixidó C; Giménez-Capitán A; Molina-Vila MÁ; Peg V; Karachaliou N; Rodríguez-Capote A; Castellví J; Rosell R
Arch Pathol Lab Med; 2018 Apr; 142(4):474-479. PubMed ID: 29565207
[TBL] [Abstract][Full Text] [Related]
7. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
[TBL] [Abstract][Full Text] [Related]
8. Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients.
Nguyen B; Cusumano PG; Deck K; Kerlin D; Garcia AA; Barone JL; Rivera E; Yao K; de Snoo FA; van den Akker J; Stork-Sloots L; Generali D
Ann Surg Oncol; 2012 Oct; 19(10):3257-63. PubMed ID: 22965266
[TBL] [Abstract][Full Text] [Related]
9. Multigene prognostic tests in breast cancer: past, present, future.
Győrffy B; Hatzis C; Sanft T; Hofstatter E; Aktas B; Pusztai L
Breast Cancer Res; 2015 Jan; 17(1):11. PubMed ID: 25848861
[TBL] [Abstract][Full Text] [Related]
10. Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test.
Kronenwett R; Bohmann K; Prinzler J; Sinn BV; Haufe F; Roth C; Averdick M; Ropers T; Windbergs C; Brase JC; Weber KE; Fisch K; Müller BM; Schmidt M; Filipits M; Dubsky P; Petry C; Dietel M; Denkert C
BMC Cancer; 2012 Oct; 12():456. PubMed ID: 23039280
[TBL] [Abstract][Full Text] [Related]
11. RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.
Lang JE; Ring A; Porras T; Kaur P; Forte VA; Mineyev N; Tripathy D; Press MF; Campo D
Ann Surg Oncol; 2018 Aug; 25(8):2261-2270. PubMed ID: 29868978
[TBL] [Abstract][Full Text] [Related]
12. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
13. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
[TBL] [Abstract][Full Text] [Related]
14. Molecular tests as prognostic factors in breast cancer.
van de Vijver MJ
Virchows Arch; 2014 Mar; 464(3):283-91. PubMed ID: 24487789
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers.
Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM
Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270
[TBL] [Abstract][Full Text] [Related]
16. Toward reliable biomarker signatures in the age of liquid biopsies - how to standardize the small RNA-Seq workflow.
Buschmann D; Haberberger A; Kirchner B; Spornraft M; Riedmaier I; Schelling G; Pfaffl MW
Nucleic Acids Res; 2016 Jul; 44(13):5995-6018. PubMed ID: 27317696
[TBL] [Abstract][Full Text] [Related]
17. Molecular Profiling of RNA Tumors Using High-Throughput RNA Sequencing: Overview of Library Preparation Methods.
Courtney SM; da Silveira WA; Hazard ES; Hardiman G
Methods Mol Biol; 2019; 1908():169-184. PubMed ID: 30649728
[TBL] [Abstract][Full Text] [Related]
18. Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.
Rantalainen M; Klevebring D; Lindberg J; Ivansson E; Rosin G; Kis L; Celebioglu F; Fredriksson I; Czene K; Frisell J; Hartman J; Bergh J; Grönberg H
Sci Rep; 2016 Nov; 6():38037. PubMed ID: 27901097
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
Belardinilli F; Capalbo C; Buffone A; Petroni M; Colicchia V; Ferraro S; Zani M; Nicolussi A; D'Inzeo S; Coppa A; Screpanti I; Gulino A; Giannini G
Clin Biochem; 2015 Sep; 48(13-14):908-10. PubMed ID: 25872148
[TBL] [Abstract][Full Text] [Related]
20. Molecular signatures in breast cancer.
Lal S; McCart Reed AE; de Luca XM; Simpson PT
Methods; 2017 Dec; 131():135-146. PubMed ID: 28669865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
